•  
  •  
 
The University of Louisville Journal of Respiratory Infections

Abstract

Introduction: Influenza vaccination is the primary strategy for prevention of influenza infection. Influenza infection can vary from mild or even asymptomatic illness to severe community-acquired pneumonia (CAP). Although many national and international investigators and organizations report annual estimates of influenza vaccine effectiveness for prevention of influenza infection in the community, few studies report estimates for the prevention of hospitalizations due to influenza CAP, the most severe form of the infection. The objective of this study is to determine the effectiveness of the influenza vaccine for prevention of hospitalization in patients with influenza-associated CAP.

Methods: This was a test-negative study using data from the first two years of the University of Louisville Pneumonia Study, a prospective, observational study of all hospitalized patients with pneumonia in Louisville, Kentucky from 6/1/2014 – 5/31/2016. Univariate and multivariate logistic models were used to evaluate the association between vaccine status and influenza-associated/non-influenza-associated CAP hospitalization. Unadjusted and adjusted vaccine effectiveness estimates were calculated.

Results: A total of 1951 hospitalized patients with CAP were included in the analysis, and 831 (43%) reported having received the influenza vaccination for the influenza season by the time they were hospitalized. A total of 152 (8%) cases of influenza-CAP were confirmed in the study population, with 63 (8%) cases confirmed in vaccinated individuals. The unadjusted vaccine effectiveness was not significant, with a point estimate of 5% (95% CI: -33%, 32%). After adjusting for potential cofounders, vaccine effectiveness was also found to not be significant with a point estimate of 8% (95% CI: -30%, 35%).

Conclusions: In conclusion, we found that, over the 2014/2015 and 2015/2016 influenza seasons, influenza vaccine was not effective for prevention of hospitalization with CAP due to influenza. More effective vaccines are necessary to prevent the most serious forms of influenza.

Funder

Pfizer, Inc.

DOI

10.18297/jri/vol2/iss1/6

vaccine effec table 1 patient characteristics.pdf (44 kB)
Table 1. Patients Characteristics (n=1951)

vaccine eft table 2 Influenza-CAP Hospitalizations by Vaccination Status.pdf (38 kB)
Table 2. 2x2 Contingency Table: Influenza-CAP Hospitalizations by Vaccination Status

Share

COinS
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.